跳至主要内容
临床试验/CTRI/2018/12/016794
CTRI/2018/12/016794已完成不适用

Evaluation of dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types

ITC Life Sciences Technology Centre1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2018年12月31日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24
试验地点
1
主要终点
Safety assessment of products

研究概览

简要总结

Single Application, occlusive, Closed Patch Test is conducted to measure the irritation potential of cosmetic products on the skin.

Objective: To evaluate the dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types.

Duration of study: 8 days study

**Kinetics: T0 (**Evaluation of test sites by Dermat and Subject,

Patch application)**,**T+30mins post patch application, T1(Patch removal, Evaluation of test sites by Dermat and Subject post 30 minutes of patch removal), T2(Evaluation of test sitesby Dermat and Subject post 24 hrs of  patch removal), T8 (Evaluation of test sitesby Dermat and Subject post 1 week of patch removal and tracking the positive cases)

Population 24 healthy subjects(12 males + 12 females) The subjects are selected on the basis of skin types:

3 males + 3 females for dry skin

3 males + 3 females for oily skin

3 males + 3 females for combination skin

3 males + 3 females for normal skin

The test area is checked for erythema and oedema caused due to the products and

Compared with positive control.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….) Subjects representing varied skin types (ideally equal representation of all 4 skin types – Oily, Normal, Dry and combination) Subjects willing to come for regular follow up and ready to follow instructions during the study period.

排除标准

  • For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic, Being asthmatic, Having eczema, psoriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing (whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhino sinusitis.

结局指标

主要结局

Safety assessment of products

时间窗: Baseline, 0 hrs, 24 hrs & 7 days

次要结局

  • Not Applicable(Not Applicable)

研究者

发起方
ITC Life Sciences Technology Centre
申办方类型
Other [fmcg]

研究点 (1)

Loading locations...

相似试验